The estrogenic activity of benzophenone and its metabolites, benzhydrol and
p-hvdroxybenzophenone, were investigated in vitro by estrogen receptor (ER
) competitive ligand binding assay and in vivo by uterotrophic assay in juv
enile female Spraeue-Dawley (SD) rats. p-Hydroxybenzophenone as well as die
thylstilbestrol and bisphenol A, known xeno-estrogenic compounds, competed
with fluorescein-labeled 17 beta -estradiol to bind human recombinant ER al
pha in a concentration-dependent manner. Fifty percent inhibitory values (I
CU) of diethylstilbestrol, bisphenol A, and p-hydroxybenzophenone were appr
oximately 10(-8), 100(-5), and 5x10(-5) M, respectively. However, neither t
he parent compound nor benzhydrol at concentrations from 10(-9) to 5x10(-4)
M impaired the binding of 17 beta -estradiol to ER alpha. Juvenile female
rats (21-days-old) were given s.c. injections of benzophenone, its metaboli
tes, and 17 beta -estradiol for 3 days. Administration of p-hydroxybenzosph
enone (100-100 mg/kg) elicited an increase in absolute and relative uterine
weights in a dose-dependent manner and 17 beta -estradiol (10 mug/kg) incr
eased uterine weight approximately fourfold relative to control. The uterin
e response caused by both compounds was accompanied by an increase in lumin
al epithelial height and stromal cells in the uterus and an increase in thi
ckness of vaginal epithelial cell layers with cornification. In contrast. b
enzophenone and benzhydrol at a dose of 400 mg/kg affected neither uterine
weight nor histological changes of the uterus and vagina. These results ind
icate that p-hydroxybenzophenone, a metabolite of benzophenone, exhibits in
trinsic xeno-estrogenic activity in the female reproductive tract.